- List
- By Topic
- On Map
- Search Details

Islets of Langerhans Transplantation | Recruiting, Not yet recruiting, Available Studies
Need help? See RSS Feeds
Choose a feed type:

Islets of Langerhans Transplantation | Recruiting, Not yet recruiting, Available Studies (37 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02846571 | Not yet recruiting | Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 70 Years (Adult, Senior) | NCT02846571 | 20160640 | August 2018 | December 2020 | December 2021 | July 27, 2016 | January 12, 2018 |
|
||
2 | NCT01897688 | Recruiting | A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients |
|
|
Interventional | Phase 3 |
|
Other |
|
|
20 | All | 18 Years to 65 Years (Adult) | NCT01897688 | STU00059469 | June 2012 | March 2020 | March 2021 | July 12, 2013 | April 20, 2018 |
|
||
3 | NCT02916680 | Recruiting | Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
4 | All | 18 Years and older (Adult, Senior) | NCT02916680 | Eye ITPL | March 2016 | April 2018 | April 2018 | September 27, 2016 | April 17, 2018 |
|
||
4 | NCT00679042 | Recruiting | Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol |
|
|
Interventional | Phase 3 |
|
Other |
|
|
1000 | All | 18 Years to 75 Years (Adult, Senior) | NCT00679042 | IND11807-2007-0330 | June 2007 | August 2017 | September 2017 | May 16, 2008 | May 30, 2017 |
|
||
5 | NCT01909245 | Recruiting | Islet Cell Transplant for Type 1 Diabetes |
|
|
Interventional | Phase 2 |
|
Other |
|
|
30 | All | 18 Years to 68 Years (Adult, Senior) | NCT01909245 | 12446 | TCD | October 2013 | July 2021 | July 2021 | July 26, 2013 | December 15, 2017 |
|
|
6 | NCT02854696 | Recruiting | Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes |
|
|
Interventional | Phase 3 |
|
Other |
|
|
40 | All | 18 Years to 65 Years (Adult) | NCT02854696 | 38RC14.453 | STABILOT | July 2016 | March 2023 | December 2023 | August 3, 2016 | March 17, 2017 |
|
|
7 | NCT02627690 | Recruiting | Nephrologic Prognosis 10 Years After Diabetes Cell Therapy |
|
|
Observational |
|
Other |
|
|
50 | All | 18 Years to 65 Years (Adult) | NCT02627690 | 2013_28 2014-A00141-46 |
PRONOCELDIAB | September 2014 | December 2019 | December 2019 | December 11, 2015 | February 2, 2017 |
|
||
8 | NCT03444064 | Recruiting | PolyTreg Immunotherapy in Islet Transplantation |
|
|
Interventional | Phase 1 |
|
Other |
|
|
18 | All | 18 Years to 68 Years (Adult, Senior) | NCT03444064 | Pro00071320 | February 1, 2018 | March 2020 | March 2021 | February 23, 2018 | February 27, 2018 |
|
||
9 | NCT02213003 | Recruiting | Allogeneic Islet Cells Transplanted Onto the Omentum |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
6 | All | 18 Years to 65 Years (Adult) | NCT02213003 | 20140144 | September 2014 | May 2019 | May 2020 | August 11, 2014 | October 9, 2017 |
|
||
10 | NCT02402439 | Recruiting | Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol |
|
|
Interventional | Phase 1 |
|
Other |
|
|
6 | All | 18 Years to 70 Years (Adult, Senior) | NCT02402439 | IGS | March 2016 | January 2021 | January 2021 | March 30, 2015 | April 5, 2018 |
|
||
11 | NCT03063229 | Recruiting | Energy Balance Following Islet Transplantation |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | All | 18 Years to 75 Years (Adult, Senior) | NCT03063229 | REC 16/SS0031 R&D: 2016/0118 | EBFIT | June 2016 | September 2018 | September 2019 | February 24, 2017 | February 24, 2017 |
|
|
12 | NCT02004964 | Recruiting | Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation |
|
Observational |
|
Other |
|
|
600 | All | 18 Years to 65 Years (Adult) | NCT02004964 | 20053135 | April 2009 | April 2019 | December 2020 | December 9, 2013 | October 9, 2017 |
|
||||
13 | NCT03073577 | Recruiting | Islet Transplantation Using PKX-001 |
|
|
Interventional | Phase 1 |
|
Other |
|
|
10 | All | 18 Years to 68 Years (Adult, Senior) | NCT03073577 | Pro00067564 | February 16, 2017 | September 2018 | January 2019 | March 8, 2017 | March 8, 2017 |
|
||
14 | NCT01630850 | Recruiting | Islet Transplantation in Patients With "Brittle" Type I Diabetes |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years to 70 Years (Adult, Senior) | NCT01630850 | 11-0684 | May 2012 | May 2018 | June 2021 | June 28, 2012 | June 9, 2017 |
|
||
15 | NCT02803905 | Recruiting | Islet Transplant Alone in OMENtum |
|
|
Interventional | Phase 2 |
|
Other |
|
|
12 | All | 18 Years to 65 Years (Adult) | NCT02803905 | ITA OMEN | ITA-OMEN | April 2016 | March 2020 | December 2020 | June 17, 2016 | February 8, 2018 |
|
|
16 | NCT01974674 | Recruiting | Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes |
|
|
Interventional | Phase 2 |
|
Other |
|
|
19 | All | 18 Years to 55 Years (Adult) | NCT01974674 | P030415 | GRIIF | July 2013 | December 2016 | January 2022 | November 1, 2013 | September 29, 2016 |
|
|
17 | NCT00678990 | Not yet recruiting | Heparinized Islets in Clinical Islet Transplantation |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
10 | All | 18 Years to 65 Years (Adult) | NCT00678990 | SAL-01 | January 2018 | December 2018 | December 2018 | May 16, 2008 | August 22, 2017 |
|
||
18 | NCT02727608 | Recruiting | Complement Inhibitor Eculizumab in Clinical Islet Transplantation |
|
|
Interventional | Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 65 Years (Adult) | NCT02727608 | ICC version 2 2014-005421-12 |
ICC | May 15, 2016 | May 2018 | June 2018 | April 4, 2016 | May 19, 2017 |
|
|
19 | NCT03079921 | Recruiting | Adrenergic System in Islet Transplantation |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
45 | All | 21 Years to 65 Years (Adult) | NCT03079921 | 826386 2R01DK091331-06 |
January 20, 2017 | December 2019 | December 2020 | March 15, 2017 | March 20, 2017 |
|
||
20 | NCT03283566 | Recruiting | Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT |
|
|
Interventional | Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 65 Years (Adult) | NCT03283566 | 17-912 | October 3, 2017 | October 3, 2019 | October 3, 2019 | September 14, 2017 | November 8, 2017 |
|
||
21 | NCT01702051 | Recruiting | Extending Indication for Islet Autotransplantation in Pancreatic Surgery |
|
Observational |
|
Other |
|
|
150 | All | 18 Years and older (Adult, Senior) | NCT01702051 | 43-09/02/2012 | AutoTx | February 2012 | October 2018 | October 2018 | October 5, 2012 | February 8, 2018 |
|
|||
22 | NCT02505893 | Recruiting | Minimal Islet Transplant at Diabetes Onset |
|
|
Interventional | Phase 2 |
|
Other |
|
|
6 | All | 18 Years to 45 Years (Adult) | NCT02505893 | DRI-MITO 1/2014 | MITO | April 2015 | May 2018 | May 2018 | July 22, 2015 | February 8, 2018 |
|
|
23 | NCT02567240 | Recruiting | Carbon Monoxide-Saturated Medium for Islet Isolation |
|
|
Interventional | Phase 1 |
|
Other |
|
|
24 | All | 18 Years to 69 Years (Adult, Senior) | NCT02567240 | Pro00040035 | January 2015 | December 2018 | December 2018 | October 2, 2015 | April 2, 2018 |
|
||
24 | NCT03427931 | Recruiting | CGM Use in Islet Transplant Recipients |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
6 | All | 18 Years and older (Adult, Senior) | NCT03427931 | 20294 | February 1, 2018 | June 30, 2018 | December 31, 2018 | February 9, 2018 | February 9, 2018 |
|
||
25 | NCT02821026 | Recruiting | Omental Islet Transplant |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
6 | All | 18 Years to 65 Years (Adult) | NCT02821026 | Pro00058260 | September 2015 | September 2018 | September 2018 | July 1, 2016 | July 1, 2016 |
|
||
26 | NCT03067324 | Recruiting | Quality Control of Pancreatic Islet Intended to Islet Graft Cells Intended to Stabilot Islet Graft Protocol |
|
Observational |
|
Other |
|
|
40 | All | 18 Years to 65 Years (Adult) | NCT03067324 | 38RC14.041 | ISLET CHIP | January 11, 2017 | December 31, 2020 | July 1, 2021 | March 1, 2017 | December 5, 2017 |
|
|||
27 | NCT03106246 | Recruiting | Circulating Extracellular Vesicles Released by Human Islets of Langerhans |
|
Observational |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT03106246 | 15-582-MUHC | December 2016 | December 2018 | July 2019 | April 10, 2017 | April 10, 2017 |
|
||||
28 | NCT02872571 | Recruiting | Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
35 | All | 18 Years and older (Adult, Senior) | NCT02872571 | 2010_49 2012-A00312-41 |
AUTOGRAFTIM | April 2013 | April 2022 | April 2022 | August 19, 2016 | February 2, 2017 |
|
|
29 | NCT01999374 | Recruiting | Long Term Follow up of Recipients of Functional Islet Allografts |
|
Observational |
|
Other |
|
|
30 | All | 18 Years to 65 Years (Adult) | NCT01999374 | 20130034 | March 2013 | March 2020 | December 2021 | December 3, 2013 | October 9, 2017 |
|
||||
30 | NCT03259256 | Recruiting | Islet Allotransplantation for Type 1 Diabetic Patients |
|
|
Interventional | Phase 3 |
|
Other |
|
|
5 | All | 18 Years to 70 Years (Adult, Senior) | NCT03259256 | Y-03 | April 23, 2017 | August 31, 2018 | June 30, 2019 | August 23, 2017 | September 26, 2017 |
|
||
31 | NCT02000687 | Recruiting | Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss |
|
Observational |
|
Other |
|
|
60 | All | 18 Years to 75 Years (Adult, Senior) | NCT02000687 | 20080127 | December 2008 | December 2020 | July 2021 | December 4, 2013 | October 9, 2017 |
|
||||
32 | NCT01346098 | Recruiting | Islet Autotransplantation in Patients at Very High-risk Pancreatic Anastomosis |
|
|
Interventional | Phase 2 |
|
Other |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT01346098 | PAN-IT | PAN-IT | July 2010 | December 2018 | April 2019 | May 2, 2011 | February 9, 2018 |
|
|
33 | NCT01379729 | Recruiting | Bet Cell Therapy in Diabetes Type 1 |
|
|
Interventional | Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 65 Years (Adult) | NCT01379729 | BK_TX_07 | May 2011 | December 2013 | May 2018 | June 23, 2011 | December 30, 2013 |
|
||
34 | NCT00678145 | Recruiting | Mechanisms Responsible for Hypoglycemia Associated Autonomic Failure |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
116 | All | 18 Years to 55 Years (Adult) | NCT00678145 | 2012-665 R01DK079974 |
HAAF | March 2008 | August 2022 | August 2022 | May 15, 2008 | January 18, 2018 |
|
|
35 | NCT03007017 | Recruiting | Novel Strategies for Innovating Deceased Donor Procurement |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT03007017 | 00071879 | January 2017 | December 2019 | December 2019 | December 30, 2016 | December 11, 2017 |
|
||
36 | NCT02464878 | Recruiting | Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
20 | All | 18 Years to 70 Years (Adult, Senior) | NCT02464878 | Islet after Kidney - AAT | January 2017 | December 2019 | January 2020 | June 8, 2015 | March 21, 2018 |
|
||
37 | NCT03415139 | Not yet recruiting | Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant |
|
|
Observational |
|
Other |
|
|
55 | All | 18 Years to 90 Years (Adult, Senior) | NCT03415139 | VICC BMT 1836 | July 2018 | April 2023 | April 2025 | January 30, 2018 | March 27, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.